Clinicians interested in Vascular Access; Infection Prevention and clinicians working in critical care and renal care settings will hear from our expert faculty Jan Hitchcock (Vascular Access Lead Nurse & Infection Prevention & Control) and Andrew Barton (Nurse Consultant IV Therapy and Vascular Access & NIVAS Chair) who will present on the latest clinical guideline updates and Medical Adhesive Skin Injury (MARSI) in relation to vascular access. Other topics explore the impact human factors in relation to vascular access; infection prevention and patient safety and a health economic and evidence review for implementation of a chlorhexidine impregnated vascular access dressing.
3M + KCI is a global advanced wound care company, offering innovative solutions from the hospital to home that improve the lives of patients in more than 90 countries. Our mission is to change the practice of medicine with solutions that speed healing, create economic value and improve patients’ lives. Our shared values drive our company’s personality, culture and priorities by providing a framework for making decision.
We are the undisputed leader in negative pressure wound therapy and the market leader in collagen dressings.
